$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$55.39B
Market Cap
38.03
P/E Ratio
23.39
EPS
$934.62
52 Week High
$510.06
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
argenx NV, based in Breda, the Netherlands, is a leading clinical-stage biotechnology company focused on developing innovative antibody-based therapies for severe autoimmune diseases, hematological disorders, and cancer. Leveraging its proprietary technology platform, argenx is advancing a robust pipeline of therapeutic candidates through multiple clinical trial phases, with the objective of delivering transformative solutions to patients with significant unmet medical needs. As the company continues to capitalize on scientific breakthroughs and expand its portfolio, argenx represents a compelling investment opportunity for institutional investors seeking exposure to the dynamic biopharmaceutical sector.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
F
PLTD
AAL
NFLX
HPE
WBD
KVUE
VHAI
WULF
MARA
UGRO
PLTR
RR
VALE
BYND
BAC
APLT
SNAP
BITF
CLSK
AMD
IREN
IRBT
IVP
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
MU
HL
KIND
IBRX
NOK
AG
APLD
BTBT
CDE
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
F
PLTD
AAL
NFLX
HPE
WBD
KVUE
VHAI
WULF
MARA
UGRO
PLTR
RR
VALE
BYND
BAC
APLT
SNAP
BITF
CLSK
AMD
IREN
IRBT
IVP
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
MU
HL
KIND
IBRX
NOK
AG
APLD
BTBT
CDE